Mpm Bioventures III Parallel Fund, LP insider trades: Somaxon Pharmaceuticals (SOMX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mpm Bioventures III Parallel Fund, LP reports to the SEC
and 10 more companies
Open-market buys and sales
46 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 9, 2012 | SOMX | ↓ Sell | 2,295,791 | $0.30 | $694K | Indirect | Jul 10, 2012 (1d) |
| Jul 2, 2012 | SOMX | ↓ Sell | 178,558 | $0.29 | $52K | Indirect | Jul 5, 2012 (3d) |
| Jun 28, 2012 | SOMX | ↓ Sell | 19,500 | $0.29 | $6K | Indirect | Jul 2, 2012 (4d) |
| Jun 19, 2012 | SOMX | ↓ Sell | 12,000 | $0.29 | $3K | Indirect | Jun 21, 2012 (2d) |
| Jun 15, 2012 | SOMX | ↓ Sell | 1,450 | $0.29 | $420 | Indirect | Jun 19, 2012 (4d) |
| Jun 6, 2012 | SOMX | ↓ Sell | 37,955 | $0.29 | $11K | Indirect | Jun 7, 2012 (1d) |
| May 31, 2012 | SOMX | ↓ Sell | 811,422 | $0.30 | $244K | Indirect | Jun 4, 2012 (4d) |
| Oct 27, 2011 | ZLCS | ↓ Sell | 738,807 | $1.03 | $761K | Indirect | Oct 28, 2011 (1d) |
| Oct 26, 2011 | ZLCS | ↓ Sell | 281,200 | $1.02 | $287K | Indirect | Oct 27, 2011 (1d) |
| Oct 24, 2011 | ZLCS | ↓ Sell | 322,100 | $1.03 | $331K | Indirect | Oct 25, 2011 (1d) |
| Oct 20, 2011 | ZLCS | ↓ Sell | 459,817 | $1.03 | $473K | Indirect | Oct 21, 2011 (1d) |
| Oct 17, 2011 | ZLCS | ↓ Sell | 19,644 | $1.02 | $20K | Indirect | Oct 19, 2011 (2d) |
| Oct 14, 2011 | ZLCS | ↓ Sell | 44,700 | $1.02 | $46K | Indirect | Oct 17, 2011 (3d) |
| Oct 12, 2011 | ZLCS | ↓ Sell | 338,300 | $40.36 | $13.7M | Indirect | Oct 13, 2011 (1d) |
| Oct 10, 2011 | ZLCS | ↓ Sell | 505,200 | $1.03 | $523K | Indirect | Oct 11, 2011 (1d) |
| Oct 6, 2011 | ZLCS | ↓ Sell | 380,232 | $1.02 | $388K | Indirect | Oct 6, 2011 (0d) |
| Sep 27, 2011 | ZLCS | ↓ Sell | 410,000 | $1.10 | $451K | Indirect | Sep 28, 2011 (1d) |
| Nov 3, 2010 | PIP | ↑ Buy | 430,000 | $3.50 | $1.5M | Indirect | Nov 5, 2010 (2d) |
| Nov 9, 2009 | PARD | ↓ Sell | 494,962 | $8.19 | $4.1M | Indirect | Nov 9, 2009 (0d) |
| Jul 8, 2009 | SOMX | ↑ Buy | 1,276,593 | $1.05 | $1.3M | Indirect | Jul 9, 2009 (1d) |
| Feb 24, 2009 | ETRM | ↑ Buy | 1,765,499 | $1.15 | $2.0M | Indirect | Feb 25, 2009 (1d) |
| Feb 12, 2009 | PLIN | ↑ Buy | 2,248 | $8.11 | $18K | Indirect | Feb 12, 2009 (0d) |
| Feb 9, 2009 | PLIN | ↑ Buy | 999 | $8.00 | $8K | Indirect | Feb 10, 2009 (1d) |
| Feb 5, 2009 | PLIN | ↑ Buy | 2,648 | $7.80 | $21K | Indirect | Feb 6, 2009 (1d) |
| Jan 27, 2009 | PLIN | ↑ Buy | 7,707 | $8.04 | $62K | Indirect | Jan 27, 2009 (0d) |
| Jan 22, 2009 | PLIN | ↑ Buy | 3,515 | $8.07 | $28K | Indirect | Jan 23, 2009 (1d) |
| Jan 20, 2009 | PLIN | ↑ Buy | 9,882 | $8.14 | $80K | Indirect | Jan 20, 2009 (0d) |
| Jan 13, 2009 | PLIN | ↑ Buy | 6,911 | $7.03 | $49K | Indirect | Jan 15, 2009 (2d) |
| Nov 14, 2008 | ARYX | ↑ Buy | 1,787,710 | $2.20 | $3.9M | Indirect | Nov 17, 2008 (3d) |
| Feb 8, 2008 | VRUS | ↓ Sell | 24,324 | $22.55 | $549K | Indirect | Feb 11, 2008 (3d) |
| Feb 4, 2008 | VRUS | ↓ Sell | 12,993 | $23.86 | $310K | Indirect | Feb 6, 2008 (2d) |
| Nov 20, 2007 | ETRM | ↑ Buy | 625,000 | $8.00 | $5.0M | Indirect | Nov 21, 2007 (1d) |
| Nov 13, 2007 | ARYX | ↑ Buy | 300,000 | $10.00 | $3.0M | Indirect | Nov 13, 2007 (0d) |
| Aug 7, 2007 | HAQ | ↑ Buy | 125,000 | $7.70 | $963K | Indirect | Aug 7, 2007 (0d) |
| May 30, 2007 | HLCS | ↑ Buy | 333,333 | $9.00 | $3.0M | Indirect | May 31, 2007 (1d) |
| May 8, 2007 | SOMX | ↓ Sell10b5-1 | 72,900 | $18.23 | $1.3M | Indirect | May 10, 2007 (2d) |
| May 4, 2007 | SOMX | ↓ Sell10b5-1 | 3,800 | $18.00 | $68K | Indirect | May 8, 2007 (4d) |
| May 2, 2007 | VRUS | ↑ Buy | 277,777 | $9.00 | $2.5M | Indirect | May 4, 2007 (2d) |
| May 2, 2007 | SOMX | ↓ Sell10b5-1 | 32,600 | $18.07 | $589K | Indirect | May 3, 2007 (1d) |
| Apr 30, 2007 | PARD | ↑ Buy | 900,000 | $6.33 | $5.7M | Indirect | May 1, 2007 (1d) |
| Apr 30, 2007 | SOMX | ↓ Sell10b5-1 | 62,600 | $18.07 | $1.1M | Indirect | May 1, 2007 (1d) |
| Dec 20, 2005 | SOMX | ↑ Buy | 318,000 | $11.00 | $3.5M | Indirect | Dec 22, 2005 (2d) |
| Oct 19, 2005 | CTRX | ↓ Sell | 170,563 | $13.00 | $2.2M | Indirect | Oct 19, 2005 (0d) |
| Oct 12, 2005 | CTRX | ↓ Sell | 252,686 | $13.00 | $3.3M | Indirect | Oct 13, 2005 (1d) |
| Sep 7, 2005 | TRCA | ↓ Sell | 8,400 | $12.00 | $101K | Indirect | Sep 12, 2005 (5d) |
| Sep 6, 2005 | TRCA | ↓ Sell | 194,826 | $12.25 | $2.4M | Indirect | Sep 7, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mpm Bioventures III Parallel Fund, LP's insider trades
Mpm Bioventures III Parallel Fund, LP is a 10% owner of Somaxon Pharmaceuticals (SOMX). Since Sep 6, 2005, it has reported 18 open-market purchases worth $32.7M and 28 sales worth $34.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (9% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Its filings also include other transactions (15 filings), conversions (10 filings), shares returned to the company (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SOMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.